Should These Drug Companies Continue to Pay a Dividend?
Should These Drug Companies Pay a Dividend?
A major battle looms as leading insulin products lose patent protection. Here are the likely winners and losers of the coming diabetes wars.
Novo Nordisk recently announced positive phase III data on its hemophilia B candidate, N9-GP, from the paradigm 2 study.